Holen Sie sich die Stockscreener-App
27.58
0.40%
0.11
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt PFE?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Pfizer Inc Aktie (PFE) Neueste Nachrichten
Public Sector Pension Investment Board Grows Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Assetmark Inc. Buys 193,859 Shares of Pfizer Inc. $PFE - MarketBeat
Daiwa Downgrades Pfizer (PFE) to Neutral Following Full-Year 2025 Earnings - Finviz
Pfizer Advances VESPER-5 Obesity and Diabetes Trial, Targeting a Key Growth Market - TipRanks
Fund Update: 753,189 PFIZER (PFE) shares added to THORNBURG INVESTMENT MANAGEMENT INC portfolio - Quiver Quantitative
Is Pfizer Inc. (PFE) One of the Best Medical Research Stocks to Buy According to Hedge Funds? - Insider Monkey
Pfizer Hemophilia And Obesity Updates Add Context To Valuation Debate - simplywall.st
Versor Investments LP Sells 37,800 Shares of Pfizer Inc. $PFE - MarketBeat
Meet the 6.3% Yield Dividend Stock That Could Soar in 2026 - Yahoo Finance
Pfizer (NYSE:PFE) Lowered to "Hold" Rating by Daiwa America - MarketBeat
Meet the 6.3% Yield Dividend Stock That Could Soar in 2026 - The Motley Fool
Pfizer Inc. $PFE Shares Sold by Prospera Financial Services Inc - MarketBeat
Pfizer Inc. $PFE Position Cut by CENTRAL TRUST Co - MarketBeat
Illinois Municipal Retirement Fund Cuts Stake in Pfizer Inc. $PFE - MarketBeat
Pfizer (PFE) Sees Mixed Options Sentiment Amid Stock Downgrade - GuruFocus
Glioblastoma Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | InovioPharma, Pfizer, Roche, ACADIA Pharma, BioNTech, Oncotelic Therapeutics - Barchart.com
Varma Mutual Pension Insurance Co Purchases 82,500 Shares of Pfizer Inc. $PFE - MarketBeat
ING Groep NV Lowers Holdings in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Purchased by LSV Asset Management - MarketBeat
Pfizer (NYSE:PFE) Cut to Neutral at Daiwa Securities Group - MarketBeat
Here Are Thursday’s Top Wall Street Analyst Research Calls: BP Plc., Borg Warner, Generac, Kraft-Heinz, MercadoLibre, Pfizer, Shopify, Valvoline, and More - 24/7 Wall St.
Madison Asset Management LLC Has $6.17 Million Stock Position in Pfizer Inc. $PFE - MarketBeat
Pfizer Shares Hit Annual Peak on Regulatory and Strategic Momentum - AD HOC NEWS
Analyst recommendations: Pfizer, Applovin, Biogen, Hilton, Snap… - marketscreener.com
Caprock Group LLC Makes New Investment in Pfizer Inc. $PFE - MarketBeat
Daiwa Securities Downgrades Pfizer to Neutral From Outperform, Price Target is $27 - marketscreener.com
Pfizer Hemophilia And Obesity Updates Reshape Growth And Valuation Outlook - Yahoo! Finance Canada
Pfizer, SEC Reach $29M Deal In Insider Trading Fund Dispute - Law360
Pfizer: A Great Opportunity Post Earnings (NYSE:PFE) - Seeking Alpha
Pfizer, SEC Reach $29M End to Scrap Over Insider Trading Settlement - Law.com
Pfizer Balances New Therapies And Pricing With Fresh Biotech Partnerships - simplywall.st
Is Now the Best Time to Buy Pfizer Stock? - The Globe and Mail
Pfizer Reports Strong Earnings OutlookUnusual Call Options Activity Shows Investors are Bullish - Yahoo Finance
Pfizer (PFE) Closes 2025 on Solid Note, Returns $9.8B to Shareholders - Finviz
Can Pfizer's New & Acquired Drugs Offset Its Looming Patent Cliff? - The Globe and Mail
Is Pfizer Stock Now A Value Trap? - Forbes
Wealthfront Advisers LLC Has $14.76 Million Holdings in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Sold by Oppenheimer Asset Management Inc. - MarketBeat
Enzyme Inhibitors Market Is Going to Boom |• Pfizer • Merck & Co. - openPR.com
Is Pfizer Stock Heading for a Fall? - Trefis
Pfizer Inc. $PFE Shares Bought by Advisors Asset Management Inc. - MarketBeat
Can Pfizer Stock Withstand These Pressures? - Trefis
Pfizer Gets $29 Million of SAC Capital Insider Trade SEC Payout - Bloomberg Law News
Pfizer (NYSE:PFE) Shares Up 2.1%Still a Buy? - MarketBeat
Pfizer (NYSE:PFE) Sets New 1-Year HighStill a Buy? - MarketBeat
Pfizer stock hits 52-week high at 27.7 USD - Investing.com
Pfizer stock jumps as PFE taps a Swiss biotech incubator — here’s what Wall Street is watching next - Bez Kabli
Smart Money Is Betting Big In PFE Options - Benzinga
Pfizer Inc. (PFE) is a trending stock: Facts to know before betting on it - MSN
Pfizer Inc. (PFE) Announces FDA’s Grant of Priority Review for HYMPAVZI® (marstacimab) sBLA - Yahoo Finance
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Pfizer Becomes Newest Partner Added to BaseLaunch's Biotech Venture Incubator - Yahoo Finance
Pfizer Inc. (PFE) Announces FDA's Grant of Priority Review for HYMPAVZI (marstacimab) sBLA - Finviz
5 Revealing Analyst Questions From Pfizer’s Q4 Earnings Call - The Globe and Mail
5 Revealing Analyst Questions From Pfizer's Q4 Earnings Call - Finviz
BridgePort Financial Solutions LLC Has $3.35 Million Holdings in Pfizer Inc. $PFE - MarketBeat
Stock Watch: Pfizer Navigates Vaccine Gains And Acquisition Pains - Citeline News & Insights
Pfizer shares gain 9% after Q3FY26 profit up 11%, revenue grows 20% - The Economic Times
Pfizer Balances TrumpRx Drug Discounts And HYMPAVZI Review With Valuation Gap - Yahoo Finance UK
Should You Buy Pfizer's Stock for Its 6.3%-Yielding Dividend? - Nasdaq
Pfizer (PFE) Tied to Drug Listings on Emerging TrumpRx Platform - GuruFocus
Freedom Capital Markets lowers Pfizer stock price target to $33 on COVID unwind - Investing.com
Indiana wins settlement for $6.25 million with global pharmaceutical companies over alleged conspiracy to increase EpiPen prices - WTHR
Entera Bio appoints former Pfizer executive Geno J. Germano as chairman of the board ahead of key milestones - marketscreener.com
Pfizer-backed firm advances potential billion-dollar drug for rare skin disease - The Business Journals
Should You Buy, Sell or Hold Pfizer Stock After a Lukewarm Q4? - The Globe and Mail
Entera Bio Attracts Former Pfizer Group President as It Enters a New Phase (NASDAQ: ENTX) - GuruFocus
Pfizer Announces 2025 Grant Recipients Driving Innovative Solutions in Cancer Care - Bioscience Association Manitoba
2.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):